Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, January 2, 2018
[ 12:00 AM ] - United States, WOPRAI
Tue, December 26, 2017
[ 12:00 AM ] - United States, WOPRAI
Fri, December 22, 2017
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Thu, December 21, 2017
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Wed, December 20, 2017
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Andrew Schenker Downgraded (THC) to Sell on, Dec 20th, 2017
Andrew Schenker of Morgan Stanley, Downgraded "Tenet Healthcare Corporation" (THC) to Sell on, Dec 20th, 2017.
Andrew has made no other calls on THC in the last 4 months.
There are 5 other peers that have a rating on THC. Out of the 5 peers that are also analyzing THC, 1 agrees with Andrew's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Scott Fidel of "Credit Suisse" Initiated at Hold and Held Target at $15 on, Thursday, November 2nd, 2017
These are the ratings of the 4 analyists that currently disagree with Andrew
- Gary Taylor of "JP Morgan" Downgraded from Hold to Sell on, Thursday, December 14th, 2017
- Ralph Giacobbe of "Citigroup" Upgraded from Hold to Strong Buy on, Tuesday, December 12th, 2017
- Brian Tanquilut of "Jefferies" Maintained at Strong Buy with Decreased Target to $20 on, Monday, October 30th, 2017
- Ana Gupte of "Leerink Swann" Maintained at Buy with Increased Target to $30 on, Monday, August 21st, 2017
